Twist Bioscience Corp TWST

Latest FY: 2025 Healthcare Biotechnology
Market Price $128.50
Market Cap $8.00B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑20.3% YoY
$376.57M
3-Yr CAGR: 22.8%
Net Income ↑62.8% YoY
-$77.67M
Net Margin: -20.6%
Free Cash Flow ↓-9.3% YoY
-$75.63M
FCF Yield: -0.95%
EPS (Diluted) ↑63.9% YoY
$-1.30
Basic: $-1.30
Return on Equity Efficiency
-16.4%
ROA: -12.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TWST)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016
FY 2017 $10.8M $-13.3M $-59.3M $-51.3M $-57.9M
FY 2018 $25.4M +136.2% $-6.8M $-71.2M -20.1% 0.00% $-66.2M $-69.9M -20.7%
FY 2019 $54.4M +113.9% $7.0M $-107.7M -51.1% 0.00% $-87.9M $-102.7M -47.0%
FY 2020 $90.1M +65.7% $28.7M $-139.9M -30.0% 0.00% $-142.3M $-152.1M -48.1%
FY 2021 $132.3M +46.9% $51.7M $-152.1M -8.7% $-3.15 0.00% $-112.2M $-139.3M +8.4%
FY 2022 $203.6M +53.8% $84.2M $-217.9M -43.2% $-4.04 -28.3% 0.00% $-124.4M $-226.2M -62.4%
FY 2023 $245.1M +20.4% $89.7M $-204.6M +6.1% $-3.60 +10.9% 0.00% $-142.5M $-170.3M +24.7%
FY 2024 $313.0M +27.7% $133.3M $-208.7M -2.0% $-3.60 0.0% 0.00% $-64.1M $-69.2M +59.4%
FY 2025 $376.6M +20.3% $191.0M $-77.7M +62.8% $-1.30 +63.9% 0.00% $-47.6M $-75.6M -9.3%
$

Valuation

Market Price $128.50
Market Cap $8.00B
Enterprise Value $7.96B
P/E Ratio N/A
P/B Ratio 16.92
FCF Yield -0.95%
Dividend Yield N/A
Shares Outstanding 62,271,300
%

Profitability & Margins

Gross Margin 50.72%
Operating Margin -36.18%
Net Margin -20.63%
Return on Equity (ROE) -16.42%
Return on Assets (ROA) -12.10%
Asset Turnover 0.59x
Revenue 3-Yr CAGR 22.76%
🛡️

Financial Health & Liquidity

Current Ratio 3.64
Cash Ratio 2.00
Debt / Equity 0.290
Debt / Assets 0.214
Cash & Equivalents $183.05M
Total Debt $137.32M
Book Value / Share $7.60
💧

Cash Flow Efficiency

Operating Cash Flow -$47.63M
Capital Expenditures (CapEx) $28.00M
Free Cash Flow -$75.63M
OCF / Revenue -12.65%
FCF / Revenue -20.08%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.30
EPS (Basic) $-1.30
Dividends / Share N/A
Book Value / Share $7.60
EPS YoY Growth 63.89%
🏛️

Balance Sheet (FY 2025)

Total Assets $641.86M
Total Liabilities $168.90M
Stockholders' Equity $472.96M
Current Assets $332.97M
Current Liabilities $91.41M